(Q47639055)

English

Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.

scientific article published on 12 February 2013

Statements

Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004 (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit